Pharma Focus Asia

Stevanato Group Invests US$145 million in Construction of New Facility in North America


Stevanato Group plans to open new manufacuting facility in North America. The new facility will provide an additional supply source for its mission critical products.


The new plant will be designed with an area covering 370,000 square feet and will be used for the production of Stevanato Group’s EZ-Fill® solutions, pre-sterilized drug containment systems for pharmaceutical use.

The new state-of-the-art facility features new production lines equipped with advanced process technologies to produce EZ-Fill® syringes and vials.

Moreover, the new facility serves as a center to support customers to provide technical support as maintenance for visual inspection, assembly and packaging equipment.

The new manufacturing site will be fully opeartional by 2023. After the completion of the new facility, it is expected to create 230 new local employees for the production, engineering and maintenance, as well as other corporate support positions.


NameStevanato Group
TypeNew Construction
BudgetUS$145 million
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Asia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024
Charles river - Endosafe Trillium